Taking people1. fázis
A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid arthritis (RA)
Key facts
- Where
- Budapest II és Szeged, MagyarországSee the 2 sites
- Phase
- 1. fázis
Where in Magyarország
- Betegapolo Irgalmasrend Budai Irgalmasrendi KorhazBudapest II, MagyarországNo longer taking part
- University of SzegedSzeged, MagyarországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Novartis Pharma AG
- Trial code
- EU 2024-520196-27-00
- Record updated
- 2026. április 1.